Get Exposure to Colombian Crude Oil With This High-Quality Growth Stock

Parex Resources Inc. (TSX:PXT) is a high-quality stock with great prospects. If you’d been put off crude oil stocks, this one might tempt you back.

| More on:

Want to get into oil and looking for Canadian stocks that aren’t affected by U.S. trade? Or are you looking for Canadian oil stocks to buy low and sell high, rather than rely solely on dividends?

We’ve got a doozy for you. Parex Resources Inc. (TSX:PXT) is a high-growth stock that is set to clean up in South America, and it’s based right here in Canada. Here’s why you should consider it if you want an alternative to home-grown oil stocks.

Calgary, now twinned with Colombia

Headquartered in our very own Calgary is one of Colombia’s most ambitious oil exploration operators. If you want a crude oil stock that looks set to ignite, this is the one. Its balance sheet is spotless, with a strong track record to match, and it’s looking at a great future.

As we mentioned above, Parex is not a dividend stock. That’s all well and good, since it means that the company reinvests in itself rather than appease shareholders with cash — unlike a lot of so-called defensive stocks getting talked up at the moment.

So, is Parex a buy? Let’s start crunching the numbers.

Should you pair up with Parex?

Parex is set for an 18.2% annual earnings growth. Think it will happen? You bet. Its past earnings-growth figures are off the chart. Its one-year earnings versus its five-year average is 14333.7% versus 1.3%. If you just did a double take, we don’t blame you. Now, take a look at the Canadian oil and gas industry average for the past year: 81.3%. That’s good — in fact, that’s great — but it doesn’t hold a torch to Parex’s exponential growth over the same period.

According to the balance sheets, Parex isn’t holding any debt — another double take. 2017 was good to Parex, with drilling successes leading to a growth in production. Sure, it holds a fair amount of physical assets and/or inventory, but that’s to be expected — it’s an oil-exploration company. With less than 300 employees, it’s light on its feet, and its multiples look good, too. All told, this is one of the healthiest stocks on the TSX going by its balance sheet.

So, it’s got a great track record, it’s super healthy, and it looks set to really rake in the cash. But how is it for value? At $24.75, it’s slightly overvalued compared to a projected future cash flow value of $21.09. However, the stock is unlikely to dip significantly any time soon, given its generally consistent climb over the last five years, so if you want in, you might as well buy now. It’s a high-quality stock with great prospects, so it’s worth it.

The bottom line

Sure, follow the crowd if you want. Go and run to defensive stocks and sit and wait for your dividends. Or you could be bold in the face of demoralizing news headlines and oscillating markets and take a gamble on high-growth stocks that could double your money. In the end, it depends on your style. But if you have a few extra dollars lying around and fancy a flutter, Parex looks like as safe an oil bet as any in today’s uncertain economic climate.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Dividend Stocks

Dividend Stocks

1 Outstanding Canadian Dividend Stock Down 10% to Buy and Hold for Years 

Explore the current challenges facing dividend stocks in the telecom sector and adapt to changing market conditions.

Read more »

Concept of multiple streams of income
Dividend Stocks

Invest $10,000 in This Dividend Stock for $580 in Passive Income

There’s no shortage of passive-income investments on the market. Here’s one that can provide $580 in annual dividends.

Read more »

person on phone leaning against outside wall with scenic view at airbnb rental property
Dividend Stocks

2 Dividend Stocks I’d Gladly Buy and Hold for Life

TELUS stock's 9% dividend yield is ripe for passive income builders as the company embarks on a noble cash flow…

Read more »

Nurse talks with a teenager about medication
Dividend Stocks

A 6.7% Dividend Stock That Remains a Standout Buy Into 2026

NorthWest Healthcare REIT’s hospital-backed leases and improving finances make it a defensive monthly payer to consider as rates ease in…

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

The 1 Canadian Stock I’m Never Selling

Some stocks you buy and sell. Others you buy and earn income. Here’s one stock I’m never selling no matter…

Read more »

data analyze research
Dividend Stocks

Where Will Dollarama Stock Be in 1 Year?

Dollarama (TSX:DOL) stock has delivered a multibagger performance. Can it keep it up?

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

Turn Any TFSA Into a $400/Month Dividend Machine

Build tax-free monthly cash flow with a TFSA, and consider Plaza Retail REIT’s steady, necessity-based income to help reach $400…

Read more »

Dividend Stocks

TFSA: The Perfect Canadian Stocks to Buy and Hold Forever

Given their strong business fundamentals, stable financial performance, and solid growth outlook, these three Canadian stocks make excellent additions to…

Read more »